Different Expression of S100A8 in Malignant and Benign Gallbladder Diseases
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Proteomic analysis is a powerful tool for complete establishment of protein expression. Comparative proteomic analysis of human bile from malignant and benign gallbladder diseases may be helpful in research into gallbladder cancer.
Our objective was to establish biliary protein content for gallbladder cancer, gallbladder adenoma, and chronic calculous cholecystitis for comparative proteomic analysis.
Bile samples were collected from patients with gallbladder cancer, gallbladder adenoma, and chronic calculous cholecystitis. Peptides of biliary proteins were separated by two-dimensional liquid chromatography then identified by tandem mass spectrometry.
Up to 544, 221, and 495 unique proteins were identified in bile samples from gallbladder cancer, gallbladder adenoma, and chronic calculous cholecystitis. Forty-three, 16, and 28 proteins with more than one unique peptide, respectively, were identified in the three groups. Among these, 30 proteins including S100A8 were overexpressed in gallbladder cancer, compared with benign gallbladder diseases. We also confirmed, by immunohistochemical analysis, that S100A8 is more abundant in tumor-infiltrating immune cells in cancerous tissue.
Compared with benign gallbladder diseases, consistently elevated S100A8 levels in malignant gallbladder bile and tissue indicate that gallbladder cancer is an inflammation-associated cancer. S100A8 may be a biomarker for gallbladder cancer.
- Pitt HA. Gallbladder cancer: what is an aggressive approach? Ann Surg. 2005;241:395–396. CrossRef
- Shukla HS. Gallbladder Cancer. J Surg Oncol. 2006;93:604–606. CrossRef
- Nedelkov D, Kiernan UA, Niederkofler EE, Tubbs KA, Nelson RW. Population proteomics: the concept, attributes, and potential for cancer biomarker research. Mol Cell Proteom. 2006;5:1811–1818. CrossRef
- Simpson RJ, Dorow DS. Cancer proteomics: from signaling networks to tumor markers. Trends Biotechnol. 2001;19:40–48. CrossRef
- Chen CY, Tsai WL, Wu HC, et al. Diagnostic role of biliary pancreatic elastase for cholangiocarcinoma in patients with cholestasis. Clin Chim Acta. 2008;390:82–89. CrossRef
- He QY, Cheung YH, Leung SY, Yuen ST, Chu KM, Chiu JF. Diverse proteomic alterations in gastric adenocarcinoma. Proteomics. 2004;4:3276–3287. CrossRef
- Petricoin EF, Liotta LA. SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer. Curr Opin Biotechnol. 2004;15:24–30. CrossRef
- Farina A, Dumonceau JM, Frossard JL, Hadengue A, Hochstrasser DF, Lescuyer P. Proteomic analysis of human bile from malignant biliary stenosis induced by pancreatic cancer. J Proteome Res. 2009;8:159–169. CrossRef
- Niu D, Feng H, Chen WN. Proteomic analysis of HBV-associated HCC: insights on mechanisms of disease onset and biomarker discovery. J Proteomics. 2010;73:1283–1290. CrossRef
- Wang JW, Peng SY, Li JT, et al. Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1. Cancer Lett. 2009;281:71–81. CrossRef
- Bonney GK, Craven RA, Prased R, et al. Circulating markers of biliary malignancy: opportunities in proteomics? Lancet Oncol. 2008;9:149–158. CrossRef
- Guerrier L, Claverol S, Finzi L, et al. Contribution of solid-phase hexapeptide ligand libraries to the repertoire of human bile proteins. J Chromatogr A. 2007;1176:192–205. CrossRef
- Kristiansen TZ, Bunkenborg J, Gronborg M, et al. A proteomic analysis of human bile. Mol Cell Proteom. 2004;3:715–728. CrossRef
- Liu Y, Wu J, Yan G, et al. Proteomic analysis of prolactinoma cells by immuno-laser capture microdissection combined with online two-dimensional nano-scale liquid chromatography/mass spectrometry. Proteome Sci. 2010;8:2. CrossRef
- Ishihama Y, Oda Y, Tabata T, et al. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteom. 2005;4:1265–1272. CrossRef
- Zhou H, Chen B, Li RX, et al. Large-scale identification of human biliary proteins from a cholesterol stone patient using a proteomic approach. Rapid Commun Mass Spectrom. 2005;19:3569–3578. CrossRef
- Lankisch TO, Metzger J, Negm AA, et al. Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis. Hepatology. 2011;53:875–884. CrossRef
- Sheikh AA, Vimalachandran D, Thompson CC, et al. The expression of S100A8 in pancreatic cancer-associated monocytes is associated with the Smad4 status of pancreatic cancer cells. Proteomics. 2007;7:1929–1940. CrossRef
- Washiro M, Ohtsuka M, Kimura F, et al. Upregulation of topoisomerase IIalpha expression in advanced gallbladder carcinoma: a potential chemotherapeutic target. J Cancer Res Clin Oncol. 2008;134:793–801. CrossRef
- Kellner U, Sehested M, Jensen PB, Gieseler F, Rudolph P. Culprit and victim—DNA topoisomerase II. Lancet Oncol. 2002;3:235–243. CrossRef
- Farina A, Dumonceau JM, Delhaye M, Frossard JL, Hadengue A, Hochstrasser DF, Lescuyer P. A step further in the analysis of human bile proteome. J Proteome Res. Epub. 02/11/2011.
- Farina A, Dumonceau JM, Lescuyer P. Proteomic analysis of human bile and potential applications for cancer diagnosis. Expert Rev Proteom. 2009;6:285–301. CrossRef
- Lo WY, Lai CC, Hua CH, et al. S100A8 is identified as a biomarker of HPV18-infected oral squamous cell carcinomas by suppression subtraction hybridization, clinical proteomic analysis, and immunohistochemistry staining. J Proteome Res. 2007;6:2143–2151. CrossRef
- Gebhardt C, Nemeth J, Angel P, Hess J. S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol. 2006;72:1622–1631. CrossRef
- Nacken W, Roth J, Sorg C, Kerkhoff C. S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity. Microsc Res Tech. 2003;60:569–580. CrossRef
- Lundy FT, Chalk R, Lamey PJ, Shaw C, Linden GJ. Identification of MRP-8 (calgranulin A) as a major responsive protein in chronic periodontitis. J Pathol. 2000;192:540–544. CrossRef
- de Seny D, Fillet M, Ribbens C, et al. Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis. Clin Chem. 2008;54:1066–1075. CrossRef
- Rafii S, Lyden D. S100 chemokines mediate bookmarking of premetastatic niches. Nat Cell Biol. 2006;8:1321–1323. CrossRef
- Hiratsuka S, Watanabe A, Aburatani H, Maru Y. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lungmetastasis. Nat Cell Biol. 2006;8:1369–1375. CrossRef
- El-Rifai W, Moskaluk CA, Abdrabbo MK, et al. Gastric cancers overexpress S100A calcium-binding proteins. Cancer Res. 2002;62:6823–6826.
- Kim HJ, Kang HJ, Lee H, et al. Identification of S100A8 and S100A9 as serological markers for colorectal cancer. J Proteome Res. 2009;8:1368–1379. CrossRef
- Hermani A, Hess J, De Servi B, et al. Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer. Clin Cancer Res. 2005;11:5146–5152. CrossRef
- Cross SS, Hamdy FC, Deloulme JC, Rehman I. Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology. 2005;46:256–269. CrossRef
- de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer. 2006;6:24–37. CrossRef
- Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539–545. CrossRef
- Goldin RD, Roa JC. Gallbladder cancer: a morphological and molecular update. Histopathology. 2009;55:218–229. CrossRef
- Different Expression of S100A8 in Malignant and Benign Gallbladder Diseases
Digestive Diseases and Sciences
Volume 58, Issue 1 , pp 150-162
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Gallbladder cancer
- Industry Sectors
- Author Affiliations
- 2. Department of General Surgery, Shaoxing People’s Hospital, Shaoxing Hospital of Zhejiang University, Zhejiang, 312000, China
- 1. Department of General Surgery, The 6th Affiliated Hospital of Shanghai Jiaotong University, 600 Yishan Road, Shanghai, 200233, China
- 3. Department of Pathology, The 6th Affiliated Hospital of Shanghai Jiaotong University, Shanghai, 200233, China